These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22844496)

  • 1. Association of MDM2 SNP309 variation with lung cancer risk: evidence from 7196 cases and 8456 controls.
    Zhuo W; Zhang L; Zhu B; Ling J; Chen Z
    PLoS One; 2012; 7(7):e41546. PubMed ID: 22844496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDM2 SNP309 variation contributes to leukemia risk: meta-analyses based on 7259 subjects.
    Zhuo W; Zhang L; Ling J; Zhu B; Chen Z
    Leuk Lymphoma; 2012 Nov; 53(11):2245-52. PubMed ID: 22563815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-Analysis.
    Ding H; Dai Y; Ning Z; Fan N; Wang Z; Li P; Zhang L; Tao Y; Wang H
    Medicine (Baltimore); 2016 Mar; 95(12):e2941. PubMed ID: 27015167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cigarette smoking, MDM2 SNP309, gene-environment interactions, and lung cancer risk: a meta-analysis.
    Bai J; Dai J; Yu H; Shen H; Chen F
    J Toxicol Environ Health A; 2009; 72(11-12):677-82. PubMed ID: 19492228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDM2 SNP309 variation increases cervical cancer risk among Asians.
    Zhuo X; Ren J; Li D; Wu Y; Zhou Q
    Tumour Biol; 2014 Jun; 35(6):5331-7. PubMed ID: 24532430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between murine double minute 2 T309G polymorphism and risk of liver cancer.
    Tang T; Song X; Yang Z; Huang L; Wang W; Tan H
    Tumour Biol; 2014 Nov; 35(11):11353-7. PubMed ID: 25119589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of MDM2 T309G polymorphism in susceptibility and prognosis of nonsmall cell lung cancer: a meta-analysis.
    Kong Q; Li P; Tian Q; Ha MW
    Genet Test Mol Biomarkers; 2014 May; 18(5):357-65. PubMed ID: 24673452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is MDM2 SNP309 Variation a Risk Factor for Head and Neck Carcinoma?: An Updated Meta-Analysis Based on 11,552 Individuals.
    Zhuo X; Ye H; Li Q; Xiang Z; Zhang X
    Medicine (Baltimore); 2016 Mar; 95(9):e2948. PubMed ID: 26945408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDM2 SNP309 variation confers the susceptibility to hepatocellular cancer: a meta-analysis based on 4271 subjects.
    Lv J; Zhu B; Zhang L; Xie Q; Zhuo W
    Int J Clin Exp Med; 2015; 8(4):5822-30. PubMed ID: 26131172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship Between Murine Double Minute 2 (MDM2) T309G Polymorphism and Endometrial Cancer Risk: A Meta-Analysis.
    Xue Z; Zhu X; Teng Y
    Med Sci Monit; 2016 Sep; 22():3186-90. PubMed ID: 27604213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MDM2 T309G polymorphism and risk of lung cancer: an updated meta-analysis of 10,186 cases and 14,155 controls.
    Tian X; Wang B; Guo J; Liu X; Zhang T; Liang C; Zhou N; Hou X; Ma Y; Yu H; Chen L; Ren Z; Fan K; Tian Q
    Panminerva Med; 2016 Dec; 58(4):341-348. PubMed ID: 27171940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of the MDM2 T309G polymorphism and gastric cancer risk.
    Song B; Duan ZY; Zhong YH; Lei N; Yang YQ; Luo KY
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6649-51. PubMed ID: 24377582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the MDM2 T309G polymorphism and leukemia risk: a meta-analysis.
    Yan YL; Han F; Tan WM; Wu CP; Qin X
    Asian Pac J Cancer Prev; 2014; 15(16):6767-72. PubMed ID: 25169523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current evidence on the relationship between murine double minute 2 T309G polymorphism and esophageal cancer susceptibility.
    Chen B; Xiong MM; Meng XL
    Dis Esophagus; 2015; 28(6):593-601. PubMed ID: 24844868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDM2 SNP309 is an ethnicity-dependent risk factor for digestive tract cancers.
    Chen B; Cao L; Hu KW; Zhang JW; Meng XL; Xiong MM
    Tumour Biol; 2014 Apr; 35(4):3431-8. PubMed ID: 24338709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDM2 309 T/G polymorphism is associated with lung cancer risk among Asians.
    Gui XH; Qiu LX; Zhang HF; Zhang DP; Zhong WZ; Li J; Xiao YL
    Eur J Cancer; 2009 Jul; 45(11):2023-6. PubMed ID: 19264476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDM2 SNP309 polymorphism and breast cancer risk: a meta-analysis.
    Zhao E; Cui D; Yuan L; Lu W
    Mol Biol Rep; 2012 Apr; 39(4):3471-7. PubMed ID: 21725850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of associations between the MDM2-T309G polymorphism and prostate cancer risk.
    Chen T; Yi SH; Liu XY; Liu ZG
    Asian Pac J Cancer Prev; 2012; 13(9):4327-30. PubMed ID: 23167337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of MDM2 SNP309 and p53 codon 72 polymorphisms on lung cancer risk and survival among non-smoking Chinese women in Singapore.
    Chua HW; Ng D; Choo S; Lum SS; Li H; Soh LY; Sabapathy K; Seow A
    BMC Cancer; 2010 Mar; 10():88. PubMed ID: 20219101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MDM2 309T>G polymorphism and ovarian cancer risk: a meta-analysis of 1534 cases and 2211 controls.
    Ma YY; Guan TP; Yao HB; Yu S; Chen LG; Xia YJ; He XJ; Wang HJ; Jiang XT; Tao HQ
    PLoS One; 2013; 8(1):e55019. PubMed ID: 23383041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.